|
Volumn 23, Issue 13, 2005, Pages 3155-
|
Treatment of brain metastases from melanoma [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FOTEMUSTINE;
TEMOZOLOMIDE;
ALKYLATING AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
BRAIN METASTASIS;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
HUMAN;
INTERVENTION STUDY;
LETTER;
MELANOMA;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
BIOASSAY;
BRAIN TUMOR;
METASTASIS;
NOTE;
REPRODUCIBILITY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BRAIN NEOPLASMS;
CLINICAL TRIALS;
DACARBAZINE;
ENDPOINT DETERMINATION;
HUMANS;
REPRODUCIBILITY OF RESULTS;
TREATMENT OUTCOME;
|
EID: 19444381246
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.05.137 Document Type: Letter |
Times cited : (5)
|
References (5)
|